BIO-electronic device to modulate nerve, tumor or organ tissue in cancer pathology and compliment chemotherapy or immunotherapy drugs to targeted cancer pathology
A bio-electronic device modulates nerve activity using high impedance electrodes to complement chemotherapy or immunotherapy, addressing cancer progression by reducing tumor proliferation and angiogenesis, thus improving treatment efficacy.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- MEDTIMO
- Filing Date
- 2025-11-21
- Publication Date
- 2026-05-28
AI Technical Summary
Despite advancements in cancer treatments like chemotherapy and immunotherapy, cancer remains a significant health issue with high mortality rates due to the activation of autonomic nervous system receptors promoting tumor proliferation, migration, and angiogenesis.
A bio-electronic device with high impedance electrodes is implanted to modulate nerve activity by applying electrical signals, combined with pharmaceutical agents, to downregulate or upregulate activity on target nerves, organs, or tumors, thereby complementing chemotherapy or immunotherapy.
The device effectively reduces cancer progression by minimizing power consumption, ensuring safety, and enhancing compatibility with magnetic resonance imaging, while providing therapeutic benefits comparable to or better than pharmaceutical agents alone.
Smart Images

Figure US2025056626_28052026_PF_FP_ABST